The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Adenosine receptors as therapeutic targets
Open accessAbstract
Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these, A1 and A2A receptors are considered the principal targets mediating caffeine’s physiological effects.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“A key mechanism underlying the interaction between caffeine and exercise is caffeine’s pharmacological action as a competitive adenosine receptor antagonist.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“Instead, competitive blockade of A1 and A2A adenosine receptors is widely regarded as the central mechanism underlying caffeine’s physiological effects during both habitual intake and exercise (Figure 1) [28,29,30,31].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“Within the range of plasma concentrations relevant to sports nutrition practice, typically micromolar levels achieved after low-to-moderate caffeine intake, caffeine’s primary mechanism of action is unlikely to involve phosphodiesterase (PDE) inhibition or direct intracellular Ca2+ release.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“This effect modulates key physiological processes such as anti-inflammatory responses, angiogenesis, and vasodilation, as illustrated in Figure 2 (left panel) [52,66,67,68].”
From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [68]
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Self-citationCalker, D. V., Müller, M., & Hamprecht, B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05236.x · Cited by 1,371
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Adenosine: A Mediator of the Sleep-Inducing Effects of Prolonged Wakefulness
Porkka-Heiskanen, T., Strecker, R. E., Thakkar, M., Bjørkum, A. A., Greene, R. W., & McCarley, R. W. (1997) · Science · doi:10.1126/science.276.5316.1265 · Cited by 1,252
Subclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Extracellular metabolism of ATP and other nucleotides
Zimmermann, H. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000309 · Cited by 990
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881 · cited 1×
“Another explanation of the paradoxical effect could be the numerous compensatory mechanisms observed in receptor-knockout mic”
BackgroundAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Klotz, K.-N., Hessling, J., Hegler, J., Owman, C., Kull, B., Fredholm, B. B., & Lohse, M. J. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005131 · Cited by 723
Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 696
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 658
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine
Huang, Z.-L., Qu, W.-M., Eguchi, N., Chen, J.-F., Schwarzschild, M. A., Fredholm, B. B., Urade, Y., & Hayaishi, O. (2005) · Nature Neuroscience · doi:10.1038/nn1491 · Cited by 640
Adenosine and sleep–wake regulation
Basheer, R., Strecker, R. E., Thakkar, M. M., & McCarley, R. W. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.06.004 · Cited by 587
Tissue distribution of adenosine receptor mRNAs in the rat
Dixon, A. K., Gubitz, A. K., Sirinathsinghji, D. J. S., Richardson, P. J., & Freeman, T. C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15561.x · Cited by 565
A2AAdenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice
Chen, J.-F., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D., Moskowitz, M. A., Fink, J. S., & Schwarzschild, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09192.1999 · Cited by 557
Ferre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 552
Stevens (2002) · doi:10.1016/s0896-6273(02)01067-x · Cited by 543
Distribution, biochemistry and function of striatal adenosine A2A receptors
Svenningsson, P. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00011-8 · Cited by 516
Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez-Llort, L., Escorihuela, R. M., Fernández-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.-J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161292398 · Cited by 505
Hillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 500
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium
Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., Robson, S. C., & Colgan, S. P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030891 · Cited by 499
Self-citationGα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C
Offermanns, S., & Simon, M. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15175 · Cited by 498
Adenosine receptor activation and nociception
Sawynok, J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01605-1 · Cited by 472
Signalling from adenosine receptors to mitogen-activated protein kinases
Schulte, G., & Fredholm, B. B. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00058-5 · Cited by 471
Ramkumar, V., Stiles, G. L., Beaven, M. A., & Ali, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85277-8 · Cited by 448
Daly, J. W., Butts-Lamb, P., & Padgett, W. (1983) · Cellular and Molecular Neurobiology · doi:10.1007/bf00734999 · Cited by 442
Sun, D., Samuelson, L. C., Yang, T., Huang, Y., Paliege, A., Saunders, T., Briggs, J., & Schnermann, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171317998 · Cited by 404
Linden, J. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90011-6 · Cited by 389
A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells
Lappas, C. M., Rieger, J. M., & Linden, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1073 · Cited by 385
Gottlieb, S. S., Brater, D. C., Thomas, I., Havranek, E., Bourge, R., Goldman, S., Dyer, F., Gomez, M., Bennett, D., Ticho, B., et al. (2002) · Circulation · doi:10.1161/hc1102.105264 · Cited by 369
Feoktistov, I., & Biaggioni, I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118245 · Cited by 363
ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and Drugs
Fredholm, B. B., Chen, J.-F., Masino, S. A., & Vaugeois, J.-M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095731 · Cited by 354
Adenosine A 2A receptor antagonist treatment of Parkinson’s disease
Bara-Jimenez, W., Sherzai, A., Dimitrova, T., Favit, A., Bibbiani, F., Gillespie, M., Morris, M. J., Mouradian, M. M., & Chase, T. N. (2003) · Neurology · doi:10.1212/01.wnl.0000073136.00548.d4 · Cited by 327
Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells
Salvatore, C. A., Tilley, S. L., Latour, A. M., Fletcher, D. S., Koller, B. H., & Jacobson, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4429 · Cited by 303
Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PD
Hauser, R. A., Hubble, J. P., Truong, D. D., & the Istradefylline US-001 Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000081227.84197.0b · Cited by 300
Adenosine A3 receptors: novel ligands and paradoxical effects
Jacobson, K. A. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01203-6 · Cited by 298
Self-citationIonic basis of the electrophysiological actions of adenosine on cardiomyocytes
Belardinelli, L., Shryock, J. C., Song, Y., Wang, D., & Srinivas, M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896004 · Cited by 289
Adenosine A3 receptor stimulation and cerebral ischemia
Von Lubitz, D. K. J. E., Lin, R. C.-S., Popik, P., Carter, M. F., & Jacobson, K. A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90523-1 · Cited by 276
Self-citationTherapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
Xu, K., Bastia, E., & Schwarzschild, M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.007 · Cited by 244
Porkka-Heiskanen, T., Alanko, L., Kalinchuk, A., & Stenberg, D. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0201 · Cited by 236
Brown, R., Ollerstam, A., Johansson, B., Skøtt, O., Gebre-Medhin, S., Fredholm, B., & Persson, A. E. G. (2001) · American Journal of Physiology - Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00470.2001 · Cited by 234
Adenosine in Tissue Protection and Tissue Regeneration
Linden, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011783 · Cited by 234
Lee, H. T., & Emala, C. W. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.3.f380 · Cited by 233
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow–derived cells
Day, Y.-J., Huang, L., McDuffie, M. J., Rosin, D. L., Ye, H., Chen, J.-F., Schwarzschild, M. A., Fink, J. S., Linden, J., & Okusa, M. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15483 · Cited by 231
BindingDB (2012) · PubMed · doi:10.7270/q2m9077b · Cited by 216
Montesinos, M. C., Desai, A., Delano, D., Chen, J., Fink, J. S., Jacobson, M. A., & Cronstein, B. N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10712 · Cited by 213
Wound Healing Is Accelerated by Agonists of Adenosine A2 (Gαs-linked) Receptors
Montesinos, M. C., Gadangi, P., Longaker, M., Sung, J., Levine, J., Nilsen, D., Reibman, J., Li, M., Jiang, C.-K., Hirschhorn, R., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1615 · Cited by 213
Odashima, M., Bamias, G., Rivera-Nieves, J., Linden, J., Nast, C. C., Moskaluk, C. A., Marini, M., Sugawara, K., Kozaiwa, K., Otaka, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.032 · Cited by 205
Linden, J., Taylor, H. E., Robeva, A. S., Tucker, A. L., Stehle, J. H., Rivkees, S. A., Fink, J. S., & Reppert, S. M. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13220-3 · Cited by 204
Auchampach, J. A., Jin, X., Wan, T. C., Caughey, G. H., & Linden, J. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.846 · Cited by 201
Bayés, M., Rabasseda, X., & Prous, J. (2002) · PubMed · Cited by 200
Monopoli, A., Lozza, G., Forlani, A., Mattavelli, A., & Ongini, E. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00034 · Cited by 200
Adenosine A2AReceptors are Colocalized with and Activate Golfin Rat Striatum
Kull, B., Svenningsson, P., & Fredholm, B. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.771 · Cited by 196
G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.
Abbracchio, M. P., Brambilla, R., Ceruti, S., Kim, H. O., von Lubitz, D. K., Jacobson, K. A., & Cattabeni, F. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10571-3 · Cited by 195
Self-citationThe role of receptor structure in determining adenosine receptor activity
Olah, M. E., & Stiles, G. L. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00051-0 · Cited by 191
The A3 Adenosine Receptor Is Highly Expressed in Tumor versus Normal Cells
Madi, L., Ochaion, A., Rath-Wolfson, L., Bar-Yehuda, S., Erlanger, A., Ohana, G., Harish, A., Merimski, O., Barer, F., & Fishman, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0651 · Cited by 189
Schulte, G., & Fredholm, B. B. (2000) · PubMed · Cited by 188
Day, Y.-J., Marshall, M. A., Huang, L., McDuffie, M. J., Okusa, M. D., & Linden, J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00348.2003 · Cited by 183
Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cells
Tilley, S. L., Wagoner, V. A., Salvatore, C. A., Jacobson, M. A., & Koller, B. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8253 · Cited by 181
Aoyama, S., Kase, H., & Borrelli, E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05848.2000 · Cited by 180
Olah, M. E., Gallo-Rodriguez, C., Jacobson, K. A., & Stiles, G. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10213-7 · Cited by 180
Self-citationInduction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists
Kohno, Y., Sei, Y., Koshiba, M., Kim, H. O., & Jacobson, K. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0331 · Cited by 178
Self-citationA2Aadenosine receptor-mediated inhibition of renal injury and neutrophil adhesion
Okusa, M. D., Linden, J., Huang, L., Rieger, J. M., Macdonald, T. L., & Huynh, L. P. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.5.f809 · Cited by 175
Sleep and its homeostatic regulation in mice lacking the adenosine A 1 receptor
Stenberg, D., Litonius, E. S., Halldner, L., Johansson, B. A., Fredholm, B. B., & Porkka‐Heiskanen, T. (2003) · Journal of Sleep Research · doi:10.1046/j.0962-1105.2003.00367.x · Cited by 174
Ryzhov, S., Goldstein, A. E., Matafonov, A., Zeng, D., Biaggioni, I., & Feoktistov, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7726 · Cited by 169
Auchampach, J. A., Rizvi, A., Qiu, Y., Tang, X.-L., Maldonado, C., Teschner, S., & Bolli, R. (1997) · Circulation Research · doi:10.1161/01.res.80.6.800 · Cited by 167
Gao, Z., Chen, T., Weber, M. J., & Linden, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5972 · Cited by 166
Self-citationTransgenic A 1 adenosine receptor overexpression increases myocardial resistance to ischemia
Matherne, G. P., Linden, J., Byford, A. M., Gauthier, N. S., & Headrick, J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6541 · Cited by 165
Feoktistov, I., Ryzhov, S., Zhong, H., Goldstein, A. E., Matafonov, A., Zeng, D., & Biaggioni, I. (2004) · Hypertension · doi:10.1161/01.hyp.0000144800.21037.a5 · Cited by 163
Yang, Z., Day, Y.-J., Toufektsian, M.-C., Ramos, S. I., Marshall, M., Wang, X.-Q., French, B. A., & Linden, J. (2005) · Circulation · doi:10.1161/01.cir.0000163586.62253.a5 · Cited by 160
Merighi, S., Mirandola, P., Milani, D., Varani, K., Gessi, S., Klotz, K., Leung, E., Baraldi, P. G., & Borea, P. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00111.x · Cited by 158
Erdmann, A. A., Gao, Z., Jung, U., Foley, J., Borenstein, T., Jacobson, K. A., & Fowler, D. H. (2005) · Blood · doi:10.1182/blood-2004-04-1407 · Cited by 156
Self-citationFunctional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts
Brackett, L. E., & Daly, J. W. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90480-4 · Cited by 153
Progress in the pursuit of therapeutic adenosine receptor antagonists
Moro, S., Gao, Z., Jacobson, K. A., & Spalluto, G. (2005) · Medicinal Research Reviews · doi:10.1002/med.20048 · Cited by 153
Self-citationBeukers, M. W., Chang, L. C. W., Künzel, J. K. V. F. D., Mulder‐Krieger, T., Spanjersberg, R. F., Brussee, J., & IJzerman, A. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049947s · Cited by 152
Adenosine receptor agonists: from basic medicinal chemistry to clinical development
Luo, Y., Burbiel, J. C., Maaß, A., & Müller, C. E. (2003) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.8.2.537 · Cited by 148
A role for central A3‐adenosine receptors
Jacobson, K. A., Nikodijević, O., Shi, D., Gallo‐Rodriguez, C., Olah, M. E., Stiles, G. L., & Daly, J. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81608-3 · Cited by 146
Self-citationMayne, M. B., Fotheringham, J., Yan, H.-J., Power, C., Bigio, M. R. D., Peeling, J., & Geiger, J. D. (2001) · Annals of Neurology · doi:10.1002/ana.1010 · Cited by 145
Gao, Z., Kim, S., Biadatti, T., Chen, W., Lee, K., Barak, D., Kim, S., Johnson, C. R., & Jacobson, K. A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020211+ · Cited by 142
Self-citationA protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury
Sun, C.-X., Young, H. W. J., Molina, J. G., Volmer, J. B., Schnermann, J. B., & Blackburn, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22656 · Cited by 140
Yu, L., Huang, Z., Mariani, J., Wang, Y., Moskowitz, M. A., & Chen, J. (2004) · Nature Medicine · doi:10.1038/nm1103 · Cited by 139
Minireview: Sleep regulation in adenosine A2Areceptor-deficient mice
Urade, Y., Eguchi, N., Qu, W., Sakata, M., Huang, Z., Chen, J., Schwarzschild, M. A., Fink, J. S., & Hayaishi, O. (2003) · Neurology · doi:10.1212/01.wnl.0000095222.41066.5e · Cited by 136
Gao, Z., Blaustein, J. B., Gross, A. S., Melman, N., & Jacobson, K. A. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00153-9 · Cited by 136
Self-citationA1adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion
Lee, H. T., Xu, H., Nasr, S. H., Schnermann, J. B., & Emala, C. W. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00185.2003 · Cited by 134
Natriuretic and Diuretic Actions of a Highly Selective Adenosine A1 Receptor Antagonist
Wilcox, C. S., Welch, W. J., Schreiner, G. F., & Belardinelli, L. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104714 · Cited by 131
Gao, Z., Li, B.-S., Day, Y., & Linden, J. M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.1.76 · Cited by 131
Self-citationHendel, R. C., Bateman, T. M., Cerqueira, M. D., Iskandrian, A. E., Leppo, J. A., Blackburn, B., & Mahmarian, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.097 · Cited by 128 · cited 1×
“Regadenoson (CVT-3146), a potent and selective A 2A AR agonist, is being evaluated in Phase III studies for the same purpose during myocardial perfusion imagin”
MethodA3 adenosine receptor as a target for cancer therapy
Fishman, P., Bar‐Yehuda, S., Madi, L., & Cohn, I. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200206000-00001 · Cited by 127
Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2AAgonists and Antagonists
Kim, S., Gao, Z., Rompaey, P. V., Gross, A. S., Chen, A., Calenbergh, S. V., & Jacobson, K. A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300431 · Cited by 125
Self-citationIncreased nociceptive response in mice lacking the adenosine A1 receptor
Wu, W., Hao, J., Halldner, L., Lövdahl, C., DeLander, G. E., Wiesenfeld‐Hallin, Z., Fredholm, B. B., & Xu, X. (2004) · Pain · doi:10.1016/j.pain.2004.11.020 · Cited by 124
Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., MacLennan, S., & Borea, P. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413772200 · Cited by 124
Yao, L., Arolfo, M. P., Dohrman, D. P., Jiang, Z., Fan, P., Fuchs, S., Janak, P. H., Gordon, A. S., & Diamond, I. (2002) · Cell · doi:10.1016/s0092-8674(02)00763-8 · Cited by 123
Linden, J. M., Thai, T., Figler, H., Jin, X., & Robeva, A. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12531-x · Cited by 123
Varani, K., Portaluppi, F., Gessi, S., Merighi, S., Ongini, E., Belardinelli, L., & Borea, P. A. (2000) · Circulation · doi:10.1161/01.cir.102.3.285 · Cited by 120
A 1 adenosine receptors mediate hypoxia-induced ventriculomegaly
Turner, C. P., Seli, M., Ment, L. R., Stewart, W. B., Jr., Yan, H., Johansson, B. A., Fredholm, B. B., Blackburn, M. R., & Rivkees, S. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1931975100 · Cited by 119
Fozard, J. R., Ellis, K. M., Dantas, M. F., Tigani, B., & Mazzoni, L. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01305-5 · Cited by 117
Blum, D. L., Galas, M., Pintor, A., Brouillet, E., Ledent, C. A., Müller, C. E., Bantubungi, K., Galluzzo, M., Gall, D., Cuvelier, L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05361.2003 · Cited by 116
Involvement of adenosine A2A receptor in sleep promotion
Satoh, S., Matsumura, H., & Hayaishi, O. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00302-1 · Cited by 116
Role of A1 adenosine receptors in regulation of vascular tone
Tawfik, H. E., Schnermann, J. B., Oldenburg, P. J., & Mustafa, S. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00684.2004 · Cited by 112
Harada, H., Asano, O., Hoshino, Y., Yoshikawa, S., Matsukura, M., Kabasawa, Y., Niijima, J., Kotake, Y., Watanabe, N., Kawata, T., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990499b · Cited by 111
Anticonvulsant and Antinociceptive Actions of Novel Adenosine Kinase Inhibitors
McGaraughty, S., Cowart, M., Jarvis, M. F., & Berman, R. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053386845 · Cited by 111
Knockout of A3 adenosine receptors reduces mouse intraocular pressure.
Avila, M. Y., Stone, R. A., & Civan, M. M. (2002) · PubMed · Cited by 109
Aggravated Brain Damage After Hypoxic Ischemia in Immature Adenosine A 2A Knockout Mice
Ådén, U., Halldner, L., Lagercrantz, H., Dalmau, I., Ledent, C. A., & Fredholm, B. B. (2003) · Stroke · doi:10.1161/01.str.0000060204.67672.8b · Cited by 109
Schindler, C. W., Karcz‐Kubicha, M., Thorndike, E. B., Müller, C. E., Tella, S. R., Ferré, S., & Goldberg, S. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706043 · Cited by 108
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells
Fishman, P., Madi, L., Bar‐Yehuda, S., Barer, F., Valle, L. D., & Khalili, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205531 · Cited by 108
Adenosine A2B‐receptor‐mediated cyclic AMP accumulation in primary rat astrocytes
Peakman, M., & Hill, S. J. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14043.x · Cited by 104
Recent advances in the neurobiology of alcoholism: the role of adenosine
Mailliard, W. S., & Diamond, I. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.10.002 · Cited by 103
Tchilibon, S., Joshi, B. V., Kim, S., Duong, H. T., Gao, Z., & Jacobson, K. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049580r · Cited by 101
Self-citationA2AAdenosine Receptor Activation Improves Survival in Mouse Models of Endotoxemia and Sepsis
Sullivan, G. W., Fang, G., Linden, J. M., & Scheld, W. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/386311 · Cited by 101
Industry forum: Progress in pursuit of therapeutic A2Aantagonists
Kase, H. (2003) · Neurology · doi:10.1212/01.wnl.0000095219.22086.31 · Cited by 99
Gene expression of adenosine receptors along the nephron
Vitzthum, H., Weiss, B., Bachleitner, W., Krämer, B. K., & Kurtz, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00490.x · Cited by 99
G-protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain
Abbracchio, M. P., Brambilla, R., Ceruti, S., Kim, H. O., Lubitz, D. K. J. E. V., Jacobson, K. A., & Cattabeni, F. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)86932-8 · Cited by 98
Self-citationAntiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
Baharav, E., Bar‐Yehuda, S., Madi, L., Silberman, D., Rath‐Wolfson, L., Halpren, M., Ochaion, A., Weinberger, A., & Fishman, P. (2005) · PubMed · Cited by 98
Müller, C. E., Diekmann, M., Thorand, M., & Ozola, V. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00785-5 · Cited by 97
Holgate, S. T. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706272 · Cited by 93
Maemoto, T., Tada, M., Mihara, T., Ueyama, N., Matsuoka, H., Harada, K., Yamaji, T., Shirakawa, K., Kuroda, S., Akahane, A., et al. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0040359 · Cited by 93
Palmer, T. M., Poucher, S. M., Jacobson, K. A., & Stiles, G. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10585-3 · Cited by 92
Self-citation[3H]MRS 1754, a selective antagonist radioligand for A2B adenosine receptors
Ji, X.-D., Kim, Y., Ahern, D. G., Linden, J. M., & Jacobson, K. A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00531-7 · Cited by 92
Self-citationJeong, L. S., Jin, D. Z., Kim, H. O., Shin, D. H., Moon, H. R., Gunaga, P., Chun, M. W., Kim, Y., Melman, N., Gao, Z., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034098e · Cited by 92
Self-citationLee, H. T., Ota‐Setlik, A., Xu, H., D’Agati, V. D., Jacobson, M. A., & Emala, C. W. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00271.2002 · Cited by 92
Dong, Q., Ginsberg, H. N., & Erlanger, B. F. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00158.x · Cited by 91
Neary, J. T., McCarthy, M., Kang, Y., & Zúñiga, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00067-6 · Cited by 90
Discovery of nonxanthine adenosine A2Areceptor antagonists for the treatment of Parkinson’s disease
Weiss, S. Μ., Benwell, K. R., Cliffe, I. A., Gillespie, R. J., Knight, A. R., Lerpiniere, J., Misra, A., Pratt, R. M., Revell, D. F., Upton, R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000095581.20961.7d · Cited by 90
Medicinal Chemistry and Pharmacology of A2B Adenosine Receptors
Volpini, R., Costanzi, S., Vittori, S., Cristalli, G., & Klotz, K. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033392264 · Cited by 89
Design, Synthesis, and Evaluation of Novel A2A Adenosine Receptor Agonists
Rieger, J. M., Brown, M. L., Sullivan, G. W., Linden, J. M., & Macdonald, T. L. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0003642 · Cited by 88
Zhao, Z., Makaritsis, K. P., Francis, C. E., Gavras, H. P., & Ravid, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00111-8 · Cited by 87
Jacobson, K. A., Gao, Z., Chen, A., Barak, D., Kim, S., Lee, K., Link, A., Rompaey, P. V., Calenbergh, S. V., & Liang, B. T. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010232o · Cited by 83
Self-citationFunctional effects of enhancing or silencing adenosine A 2b receptors in cardiac fibroblasts
Chen, Y., Epperson, S. A., Makhsudova, L., Ito, B. R., Suárez, J., DILLMANN, W. H., & Villarreal, F. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00217.2004 · Cited by 83
Guo, Y., Bolli, R., Bao, W., Wu, W., Richard G. Black, Jr., Murphree, S. S., Salvatore, C., Jacobson, M. A., & Auchampach, J. A. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1338 · Cited by 82
Gene Dosage-Dependent Effects of Cardiac-Specific Overexpression of the A 3 Adenosine Receptor
Black, R. G., Guo, Y., Ge, Z., Murphree, S. S., Prabhu, S. D., Jones, W. K., Bolli, R., & Auchampach, J. A. (2002) · Circulation Research · doi:10.1161/01.res.0000028007.91385.ee · Cited by 82
Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry
Zambrowicz, B., Turner, C. A., & Sands, A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.04.002 · Cited by 82
Bridges, A. J., Bruns, R. F., Ortwine, D. F., Priebe, S. R., Szotek, D. L., & Trivedi, B. K. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00402a004 · Cited by 81
Yacoubi, M. E., Ledent, C. A., Parmentier, M., Daoust, M., Costentin, J., & Vaugeois, J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00173-8 · Cited by 80
Tracey, W. R. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00112-6 · Cited by 79
Schulte, G., & Fredholm, B. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1137 · Cited by 78
Lü, J., Pierron, A., & Ravid, K. (2003) · PubMed · Cited by 77
Talukder, M. A. H., Morrison, R. R., Jacobson, M. A., Jacobson, K. A., Ledent, C. A., & Mustafa, S. J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00964.2001 · Cited by 77
Self-citationActivation of A3Adenosine Receptor Protects Against Doxorubicin-induced Cardiotoxicity
Shneyvays, V., Mamedova, L. K., Zinman, T., Jacobson, K. A., & Shainberg, A. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1387 · Cited by 76
Self-citationA2BReceptors Mediate Antimitogenesis in Vascular Smooth Muscle Cells
Dubey, R. K., Gillespie, D. G., Shue, H., & Jackson, E. K. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.267 · Cited by 75
Giffin, N., Kowacs, F., Libri, V., Williams, P. M., Goadsby, P. J., & Kaube, H. (2003) · Cephalalgia · doi:10.1046/j.1468-2982.2003.00511.x · Cited by 72
Ji, X. D., & Jacobson, K. A. (1999) · PubMed · Cited by 71
Self-citationCardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction
Yang, Z., Cerniway, R. J., Byford, A. M., Berr, S. S., French, B. A., & Matherne, G. P. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00741.2001 · Cited by 71
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416
Moresco, R. M., Todde, S., Belloli, S., Simonelli, P., Panzacchi, A., Rigamonti, M. M., Galli-Kienle, M., & Fazio, F. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1688-5 · Cited by 70
Allosteric Modulation of the Adenosine Family of Receptors
Gao, Z., Kim, S., IJzerman, A. P., & Jacobson, K. A. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054023242 · Cited by 70
Self-citationSelective A2Aadenosine receptor activation reduces skin pressure ulcer formation and inflammation
Peirce, S. M., Skalak, T. C., Rieger, J. M., Macdonald, T. L., & Linden, J. M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h67 · Cited by 69
N-Substituted Adenosines as Novel Neuroprotective A1 Agonists with Diminished Hypotensive Effects
Knutsen, L. J. S., Lau, J. F., Petersen, H., Thomsen, C., Weis, J. U., Shalmi, M., Judge, M. E., Hansen, A. J., & Sheardown, M. J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm960682u · Cited by 68
Cooper, J., Hill, S. J., & Alexander, S. P. H. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701401 · Cited by 68
Baraldi, P. G., Cacciari, B., Spalluto, G., Bergonzoni, M., Dionisotti, S., Ongini, E., Varani, K., & Borea, P. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9708689 · Cited by 68
Perreira, M., Jiang, J., Klutz, A. M., Gao, Z., Shainberg, A., Lu, C., Thomas, C. J., & Jacobson, K. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050221l · Cited by 66
Self-citationGenetic Deletion of the A 1 Adenosine Receptor Limits Myocardial Ischemic Tolerance
Reichelt, M. E., Willems, L., Molina, J. G., Sun, C.-X., Noble, J. C., Ashton, K. J., Schnermann, J. B., Blackburn, M. R., & Headrick, J. P. (2005) · Circulation Research · doi:10.1161/01.res.0000156075.00127.c3 · Cited by 66
Astrocytes and neurons: different roles in regulating adenosine levels
Parkinson, F. E., Xiong, W., & Zamzow, C. R. (2005) · Neurological Research · doi:10.1179/016164105x21878 · Cited by 65
Wang, J., Drake, L., Sajjadi, F., Firestein, G. S., Mullane, K., & Bullough, D. A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00901-6 · Cited by 65
Li, X., Conklin, D. R., Pan, H., & Eisenach, J. C. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047951 · Cited by 65
Yang, H., Avila, M. Y., Peterson-Yantorno, K., Coca‐Prados, M., Stone, R. A., Jacobson, K. A., & Civan, M. M. (2005) · Current Eye Research · doi:10.1080/02713680590953147 · Cited by 65
Self-citationCross, H. R., Murphy, E., Black, R. G., Auchampach, J. A., & Steenbergen, C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00335.2002 · Cited by 64
Fossetta, J. D., Jackson, J. A., Deno, G., Fan, X., Du, X., Bober, L. A., Soudé-Bermejo, A., de Bouteiller, O., Caux, C., Lunn, C. A., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.342 · Cited by 64
Intervention with Spinal NMDA, Adenosine, and NO Systems for Pain Modulation
Gordh, T., Karlsten, R., & Kristensen, J. D. (1995) · Annals of Medicine · doi:10.3109/07853899509031964 · Cited by 63
Schulte, G., Sommerschild, H. T., Yang, J., Tokuno, S., Goiny, M., Lövdahl, C., Johansson, B. A., Fredholm, B. B., & Valen, G. (2004) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01350.x · Cited by 63
Okamura, T., Kurogi, Y., Hashimoto, K., Sato, S., Nishikawa, H., Kiryu, K., & Nagao, Y. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.099 · Cited by 63
Peng, H., Kumaravel, G., Yao, G., Li, S., Wang, J., van Vlijmen, H., Bohnert, T., Huang, C., Vu, C. B., Ensinger, C. L., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0494321 · Cited by 62
Gessi, S., Varani, K., Merighi, S., Cattabriga, E., Pancaldi, C., Szabadkai, Y., Rizzuto, R., Klotz, K., Leung, E., Lennan, S. M., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009225 · Cited by 62
Cerniway, R. J., Yang, Z., Jacobson, M. A., Linden, J. M., & Matherne, G. P. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.4.h1751 · Cited by 60
Effects of A3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart
Harrison, G. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00424-2 · Cited by 59
Reid, E. A., Kristo, G., Yoshimura, Y., Ballard‐Croft, C., Keith, B. J., Mentzer, R. M., & Lasley, R. D. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01009.2004 · Cited by 58
Kim, S., Ravi, G., Hoffmann, C., Jung, Y.-J., Kim, M., Chen, A., & Jacobson, K. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00839-0 · Cited by 58
Self-citationOlsson, T. T., Cronberg, T., Rytter, A., Asztély, F., Fredholm, B. B., Smith, M., & Wieloch, T. W. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03564.x · Cited by 58
The discovery and synthesis of novel adenosine receptor (A2A) antagonists
Matasi, J. J., Caldwell, J. P., Hao, J., Neustadt, B. R., Arik, L., Foster, C. J., Lachowicz, J. E., & Tulshian, D. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.019 · Cited by 57
Mozzicato, S., Joshi, B. V., Jacobson, K. A., & Liang, B. T. (2003) · The FASEB Journal · doi:10.1096/fj.03-0592fje · Cited by 55
Self-citationTracey, W. R., Magee, W. P., Oleynek, J. J., Hill, R. J. W., Smith, A. H., Flynn, D. M., & Knight, D. R. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00411.2003 · Cited by 53
Fresco, P., Diniz, C., & Gonçalves, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.015 · Cited by 53
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats
Solinas, M., Ferré, S., Antoniou, K. M., Quarta, D., Justinová, Z., Hockemeyer, J., Pappas, L. A., Segal, P. N., Wertheim, C. E., Müller, C. E., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2081-6 · Cited by 52
Stewart, M., Steinig, A. G., Ma, C., Song, J., McKibben, B. P., Castelhano, A. L., & MacLennan, S. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.026 · Cited by 51
Headrick, J. P., Gauthier, N. S., Morrison, R., & Matherne, G. P. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.4.h1690 · Cited by 48
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils
Lubitz, D. K. J. E. V., Lin, R. C. S., Paul, I. A., Beenhakker, M. P., Boyd, M., Bischofberger, N., & Jacobson, K. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00667-x · Cited by 48
Self-citationShneyvays, V., Leshem, D., Zinman, T., Mamedova, L. K., Jacobson, K. A., & Shainberg, A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01157.2004 · Cited by 48
Self-citationDonoso, M. V., López, R., Miranda, R., Briones, R., & Huidobro-Toro, J. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00548.2004 · Cited by 46
Gao, Z., Duong, H. T., Sonina, T., Kim, S., Rompaey, P. V., Calenbergh, S. V., Mamedova, L., Kim, H. O., Kim, M. J., Kim, A. Y., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050968b · Cited by 45
Self-citationEffector coupling of stably transfected human A3 adenosine receptors in CHO cells
Englert, M., Quitterer, U., & Klotz, K. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01071-7 · Cited by 44
Jacobson, K. A., Ohno, M., Duong, H. T., Kim, S., Tchilibon, S., Česnek, M., Holý, A., & Gao, Z. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.12.010 · Cited by 43
Self-citationMoro, S., Bacilieri, M., Cacciari, B., & Spalluto, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0502440 · Cited by 42
Cassada, D. C., Tribble, C. G., Long, S. M., Kaza, A. K., Linden, J. M., Rieger, J. M., Rosin, D. L., Kron, I. L., & Kern, J. A. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)03793-1 · Cited by 42
Rivo, J., Zeira, E., Galun, E., & Matot, I. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00620.x · Cited by 40
Zhao, Z., Yaar, R., Ladd, D., Cataldo, L. M., & Ravid, K. (2002) · Microvascular Research · doi:10.1006/mvre.2001.2366 · Cited by 39
Feoktistov, I., & Biaggioni, I. (1996) · Drug Development Research · Cited by 39
Szentmiklosi, A. J., Újfalusi, A., Cseppentö, A., Nosztray, K., Kovacs, P. L., & Szabó, J. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169083 · Cited by 38
Preconditioning of rat hearts by adenosine A1 or A3 receptor activation
de Jonge, R., Out, M., Maas, W. J., & de Jong, J. W. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01611-9 · Cited by 38
Myocardial Function in the Working Mouse Heart Overexpressing Cardiac A1Adenosine Receptors
Gauthier, N. S., Headrick, J. P., & Matherne, G. P. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0585 · Cited by 38
Ellenbogen, K. A., O’Neill, G., Prystowsky, E. N., Camm, A. J., Meng, L., Lieu, H. D., Jerling, M., Shreeniwas, R., Belardinelli, L., & Wolff, A. A. (2005) · Circulation · doi:10.1161/circulationaha.104.510982 · Cited by 38
Shneyvays, V., Zinman, T., & Shainberg, A. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.03.004 · Cited by 37
Auchampach, J. A., Jin, X., Moore, J. M., Wan, T. C., Kreckler, L. M., Ge, Z., Narayanan, J., Whalley, E. T., Kiesman, W. F., Ticho, B., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057943 · Cited by 37
Bauer, A., Langen, K., Bidmon, H. J., Holschbach, M. H., Weber, S., Olsson, R. A., Coenen, H. H., & Zilles, K. (2005) · PubMed · Cited by 37
Pingle, S. C., Mishra, S., Marcuzzi, A., Bhat, S. G., Sekino, Y., Rybak, L. P., & Ramkumar, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405666200 · Cited by 36
Adenosine Inhibits PDGF-Induced Growth of Human Glomerular Mesangial Cells Via A2BReceptors
Dubey, R. K., Gillespie, D. G., Mi, Z., & Jackson, E. K. (2005) · Hypertension · doi:10.1161/01.hyp.0000178464.63393.88 · Cited by 35
Martin, P. L., Wysocki, R. J., Barrett, R. J., May, J. M., & Linden, J. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12299-4 · Cited by 35
Rubino, A., Ralevic, V., & Burnstock, G. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39503-0 · Cited by 33
Research works printed but not linked: 1
- Ji, X. D. & Jacobson, K. A. [3H]-ZM241385 as a radioligand at recombinant human A2B adenosine receptors. Drug Des. Discov. 16, 217–226 (1999).
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Physiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,585
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
“Selective agonists and antagonists for all four adenosine receptor subtypes are available (Müller, 2000a,b; Yan et al., 2003; Jacobson and Gao, 2006; Müller and Ferré, 2007; Elzein and Zablocki, 2008; Müller and Jacobson, 2011).”
BackgroundSelf-citationAdenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
“However, it is now known to be also linked to various kinase pathways including protein kinase C (PKC), phosphoinositide 3 (PI3) kinase and mitogen-activated protein (MAP) kinase”
Background
Metadata
- Authors
- Jacobson, K. A., & Gao, Z.-G.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Jacobson, Kenneth A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-03
- Volume
- 5
- Issue
- 3
- Pages
- 247-264
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3463109
- OpenAlex
- W1985598247
- Cited by
- 1,431
- References
- 215
- Citations by year
- 2026: 34 · 2025: 50 · 2024: 52 · 2023: 55 · 2022: 80 · 2021: 58 · 2020: 65 · 2019: 79 · 2018: 66 · 2017: 59 · 2016: 65 · 2015: 64 · 2014: 80 · 2013: 80 · 2012: 83
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK031117)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- adenosine receptors, adenosine receptor agonists, adenosine receptor antagonists, selective ligands, caffeine, cardiovascular disease, ischemic diseases, sleep disorders, inflammatory diseases, cancer, neurological disorders, drug development
- MeSH terms
- Animals, Disease, Drug Therapy, Humans, Ligands, Structure-Activity Relationship, Molecular Structure, Signal Transduction, Receptors, Purinergic P1, Purinergic P1 Receptor Agonists, Purinergic P1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.